Related Experiment Videos

Recurrent tinea pedis: a double blind study on the prophylactic use of fenticonazole powder

G Albanese1, R Di Cintio, P Giorgetti

  • 1Department of Dermatology, S. Gerardo Hospital, Monza, Italy.

Mycoses
|May 1, 1992
PubMed

Insights

Topical fenticonazole powder may prevent tinea pedis recurrence. This antifungal treatment, applied after initial cure, significantly reduced relapses in patients with persistent predisposing factors like maceration.

Area of Science:

  • Dermatology
  • Mycology
  • Pharmacology

Background:

  • Tinea pedis is a prevalent, recurrent fungal infection.
  • Eradication is challenging due to persistent predisposing factors such as maceration.
  • Preventive strategies are crucial for managing frequent relapses.

Purpose of the Study:

  • To evaluate the efficacy of topical fenticonazole powder in preventing tinea pedis recurrence.
  • To assess the role of antifungal powders in managing persistent fungal infections.

Main Methods:

  • Thirty patients with tinea pedis were initially cured with topical antifungal treatment.
  • Diagnosis and cure were confirmed via microscopic and cultural mycological analyses.
  • A subsequent 4-month double-blind study compared fenticonazole powder against a placebo, with clinical and mycological assessments.

Main Results:

  • Fenticonazole powder treatment was confirmed effective in reducing relapse frequency.
  • Statistical evaluation supported the therapeutic benefits of the antifungal powder.
  • The study demonstrated a significant decrease in tiresome relapses.

Conclusions:

  • Topical fenticonazole powder is effective in the preventive therapy of tinea pedis.
  • Antifungal powders can help manage recurrent dermatophytic infections, especially when predisposing factors persist.
  • This approach offers a viable strategy to reduce the burden of tinea pedis relapses.

Related Concept Videos